MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q52211232, #quickstatements; #temporary_batch_1711486342377 |
ReferenceBot (talk | contribs) Changed an Item |
||
Property / cites work | |||
Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Bivariate Sequential Designs for Phase II Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Designs for Group Sequential Phase II Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: A Bayesian Approach to the Design of Phase II Clinical Trials / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank | |||
Normal rank |
Revision as of 17:13, 30 May 2024
scientific article; zbMATH DE number 1525738
Language | Label | Description | Also known as |
---|---|---|---|
English | MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION |
scientific article; zbMATH DE number 1525738 |
Statements
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (English)
0 references
27 February 2001
0 references
multiple-stage stopping rule
0 references
multivariate endpoint
0 references
missing data
0 references
clinical trial
0 references
oncology
0 references